Sundia Meditech Company, Ltd. offersa wide range of drug discovery and development services which includes drug metabolism and pharmacokinetics (dmpk). It belongs to drug discovery and research category. Features: it has established various in vitro assays that help clients efficiently and cost-effectively conduct compound characterizations of lead molecules. It is in vitro assays include metabolic stability using microsome/s9 and hepatocytes, mdck and caco-2 cell permeability, plasma protein binding, cyp450 (3a4, 1a2, 2d6, 2c9, 2c19, 2e1) inhibition, time-dependent inhibition, reactive metabolite screening, and metabolite identification. Contact us for more information.
